We included only survivors of COVID-19, within 4 weeks after COVID-19 diagnosis, so we may have missed the period of critical illness when signs of deterioration of insulin function and hypermetabolism may be more pronounced and prevalent. This evidence concerns the gene INS and COVID-19.